People most at risk for disease are often left out of clinical trials. But demand grows for assurances that the COVID-19 vaccine trial be diverse.
assess the safety and best doses of vaccines in small groups of people. Phase 3 trials test the efficacy of the drug in tens of thousands of people.
Investigators at nearly 90 sites across the U.S. are preparing to recruit participants for Moderna’s Phase 3 trial. , executive associate dean at the Emory University School of Medicine, will seek 750 volunteers at three Atlanta-area sites. Half will receive the vaccine; half, placebo injections.recruiting minorities for HIV trials and expects similar results with the COVID-19 vaccine trial. “We’re trying to do our best to get out to the communities that are most at risk,” he said.
Meanwhile, vaccine volunteers like Cisneros just want the Phase 3 trials to start. He said it’s a way for him to take action at a time when the U.S. government has failed to protect minorities, the elderly and other vulnerable people. “Government is supposed to help those who can’t protect themselves,” he said. “It appears to me the only thing they want to protect is people with money, people with guns — and not brown people like me.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The CDC Updated Its Guidelines for When People With COVID-19 Can Be in Public AgainThere are three important criteria to meet.
Read more »
How A 60-Year-Old Drug Became Our Best Hope For Saving People With COVID-19Dexamethasone, a steroid that appears promising for COVID-19 patients, has a long and storied history in medicine. FiveThirtyEight talks with experts about its many uses, and explores how it might save lives in this pandemic.
Read more »
Trump’s ‘Somber’ COVID-19 Press Briefing Quickly Returns to Usual MisinformationTrump abandoned the vaguely presidential tone he displayed yesterday for his usual mix of false claims and self-promotion.
Read more »
One-third of COVID-19 patients who aren't hospitalized have long-term illness, CDC saysAs many as a third of coronavirus patients who were never sick enough to be hospitalized are not back to their usual health up to 3 weeks after their diagnosis, new CDC report finds.
Read more »